Comparing specialist medical care with specialist medical care plus the Lightning Process for chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME): study protocol for a randomised controlled trial (SMILE Trial).
Comparing specialist medical care with specialist medical care plus the Lightning Process for chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME): study protocol for a randomised controlled trial (SMILE Trial).
复制标题
DOI:
10.1186/1745-6215-14-444
复制
发表时间:
2013-12-26
期刊:
影响因子:
2.5
通讯作者:
Montgomery A
中科院分区:
文献类型:
--
作者:
Crawley E;Mills N;Hollingworth W;Deans Z;Sterne JA;Donovan JL;Beasant L;Montgomery A
Chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) is a relatively common and potentially serious condition with a limited evidence base for treatment. Specialist treatment for paediatric CFS/ME uses interventions recommended by National Institute for Health and Clinical Excellence (NICE) including cognitive behavioural therapy, graded exercise therapy and activity management. The Lightning Process® (LP) is a trademarked intervention derived from osteopathy, life-coaching and neuro-linguistic programming, delivered over three consecutive days as group sessions. Although over 250 children with CFS/ME attend LP courses each year, there are no reported studies on the effectiveness or cost-effectiveness. This pragmatic randomised controlled trial is set within a specialist paediatric CFS/ME service in the south west of England. Children and young people with CFS/ME (n = 80 to 112), aged 12 to 18 years old will be randomised to specialist medical care (SMC) or SMC plus the LP. The primary outcome will be physical function (SF-36 physical function short form) and fatigue (Chalder Fatigue Scale). This study will tell us whether adding the LP to SMC is effective and cost-effective compared to SMC alone. This study will also provide detailed information on the implementation of the LP and SMC. Current Controlled Trials ISRCTN81456207 (31 July 2012).
登录
查看更多内容
影响因子:
4.1
作者:
Lloyd, Samantha;Chalder, Trudie;Rimes, Katharine A.
通讯作者:
Rimes, Katharine A.
影响因子:
3.3
作者:
Brooks, R
通讯作者:
Brooks, R
影响因子:
4.4
作者:
REILLY, MC;ZBROZEK, AS;DUKES, EM
通讯作者:
DUKES, EM
影响因子:
7.6
作者:
Jones, JF;Nisenbaum, R;Reeves, WC
通讯作者:
Reeves, WC
影响因子:
6.9
作者:
Chalder, T.;Deary, V.;Walwyn, R.
通讯作者:
Walwyn, R.